Journal Mobile Options
Table of Contents
Vol. 65, No. 3, 2008
Issue release date: April 2008

Vulvodynia: Case Report and Review of Literature

Gumus I.I. · Sarifakioglu E. · Uslu H. · Turhan N.O.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Vulvodynia is defined as chronic vulvar burning, stinging, rawness, soreness or pain in the absence of objective clinical or laboratory findings to explain these symptoms. Vulvodynia is a chronic pain syndrome affecting up to 18% of the female population and is generally regarded as an underdiagnosed difficult to treat gynecological disorder. An increasing number of patients present with symptoms of vulvar pain, soreness, burning or irritation, which becomes chronic. Vulvodynia is a term used to describe chronic burning and/or pain in the vulva without objective clinical or laboratory findings to explain these symptoms. We present a case of vulvodynia accompanying somatoform disorder and depression.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Weisfogel E: Battle with a unicorn: the burning vulva. Proc 3rd Cong Int Soc Study Vulvar Dis, Cocoyoc, 1976.
  2. McKay M: Burning vulva syndrome, report of the ISSVD taskforce. J Reprod Med 1984;29:457.
  3. McKay M: Subsets of vulvodynia. J Reprod Med 1988;33:695–698.
  4. Moyal-Barracco M, Lynch PJ: 2003 ISSVD terminology and classification of vulvodynia: a historical perspective. J Reprod Med 2004;49:772–777.
  5. Edwards L: New concepts in vulvodynia. Am J Obstet Gynecol 2003;189:24–30.

    External Resources

  6. Harlow BL, Stewart EG: A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc 2003;58:82–88.
  7. Arnold LD, Bachman GA, Rosen R, Rhoads GG: Assessment of vulvodynia symptoms in a sample of US women: a prevalence survey with a nested case control study. Am J Obstet Gynecol 2007;196:128e1–128e6.
  8. Prayson RA, Stoler MH, Hart WR: Vulvar vestibulitis: a histopathologic study of 36 cases, including human papillomavirus in situ hybridization analysis. Am J Surg Pathol 1995;19:154–160.
  9. Sarma AV, Foxman B, Bayirli B, Haefner H, Sobel JD: Epidemiology of vulvar vestibulitis syndrome: an exploratory case-control study. Sex Transm Infect 1999;75:320–326.
  10. Bohm-Starke N, Hilliges M, Falconer C, Rylander E: Increased intraepithelial innervation in women with vulvar vestibulitis syndrome. Gynecol Obstet Invest 1998;46:256–260.
  11. Masterson BJ, Galask RP, Ballas ZK: Natural killer cell function in women with vestibulitis. J Reprod Med 1996;41:562–568.
  12. Ashman RB, Ott AK: Autoimmunity as a factor in recurrent vaginal candidiasis and the minor vestibular gland syndrome. J Reprod Med 1989;34:264–266.
  13. Bornstein J, Shapiro S, Goldshmid N, Goldik Z, Lahat N, Abramovici H: Severe vulvar vestibulitis: relation to HPV infection. J Reprod Med 1997;42:514–518.
  14. McKay M: Vulvodynia: diagnostic patterns. Dermatol Clin 1992;10:423–433.
  15. Bazin S, Bouchard C, Brisson J, Morin C, Meisels A, Fortier M: Vulvar vestibulitis syndrome: an exploratory case-control study. Obstet Gynecol 1994;83:47–50.
  16. Shafik A: Pudendal canal syndrome as a cause of vulvodynia and its treatment by pudendal nerve decompression. Eur J Obstet Gynecol Reprod Biol 1998;80:215–220.
  17. Cox JT: Deconstructing vulval pain. Lancet 1995;345:53.
  18. Bohm-Starke N, Hilliges M, Falconer C, Rylander E: Neurochemical characterization of the vestibular nerves in women with vulvar vestibulitis syndrome. Gynecol Obstet Invest 1999;48:270–275.
  19. Aikens JE, Reed BD, Gorenflo DW, Haefner HK: Depressive symptoms among women with vulvar dysesthesia. Am J Obstet Gynecol 2003;189:462–466.
  20. Wylie K, Hallam-Jones R, Harrington C: Psychological difficulties within a group of patients with vulvodynia. J Psychosom Obstet Gynaecol 2004;25:257–265.
  21. Edwards L, Mason M, Phillips M, Norton J, Boyle M: Childhood sexual and physical abuse: incidence in patients with vulvodynia. J Reprod Med 1997;42:135–139.
  22. Reed BD, Haefner HK, Punch MR, Roth RS, Gorenflo DW, Gillespie BW: Psychosocial and sexual functioning in women with vulvodynia and chronic pelvic pain: a comparative evaluation. J Reprod Med 2000;45:624–632.
  23. Consoli SG: Psychosomatic approach of vulvodynia. Gynecol Obstet Fertil 2003;31:948–953.
  24. Lynch PJ: Vulvodynia: a syndrome of unexplained vulvar pain, psychologic disability and sexual dysfunction. J Reprod Med 1986;31:773–780.
  25. Masheb RM, Lozano-Blanco C, Kohorn EI, Minkin MJ, Kerns RD: Assessing sexual function and dyspareunia with the Female Sexual Function Index (FSFI) in women with vulvodynia. J Sex Marital Ther 2004;30:315–324.
  26. Slone S, Reynolds L, Gall S, Peiper S, Martin A, Ackermann D, et al: Localization of chromogranin, synaptophysin, serotonin, and CXCR2 in neuroendocrine cells of the minor vestibular glands: an immunohistochemical study. Int J Gynecol Pathol 1999;18:360–365.
  27. Chadha S, Gianotten WL, Drogendijk AC, Weijmar Schultz WC, Blindeman LA, van der Meijden WI: Histopathologic features of vulvar vestibulitis. Int J Gynecol Pathol 1998;17:7–11.
  28. Glazer HI, Jantos M, Hartmann EH, Swencionis C: Electromyographic comparisons of the pelvic floor in women with dysesthetic vulvodynia and asymptomatic women. J Reprod Med 1998;43:959–962.
  29. Graziottin A, Castoldi E, Montorsi F, Salonia A, Maga T: Vulvodynia: the challenge of ‘unexplained’ genital pain. J Sex Marital Ther 2001;27:503–512.
  30. Tschanz C, Salomon D, Skaria A, Masouye I, Vecchietti GL, Harms M: Vulvodynia after CO2 laser treatment of the female genital mucosa. Dermatology 2001;202:371–372.
  31. Wakelin SH, Marren P: Lichen sclerosis in women. Clin Dermatol 1997;15:155–169.
  32. Pernicaiaro C, Bustamante A, Gutierrez M: Two cases of vulvodynia with unusual causes. Acta Dermatol Venerol 1993;73:227–228.

    External Resources

  33. Lambiris A, Greaves MW: Urticaria: increasingly recognised but not adequately highlighted cause of dyspareunia and vulvodynia. Acta Dermatol Venereol (Stockh) 1996;77:160–166.

    External Resources

  34. Lewis F, Harrington CI: Use of magnetic resonance imaging in vulvodynia. J Reprod Med 1997;42:169.
  35. Shafik A: Pudendal canal syndrome as a cause of vulvodynia and its treatment by pudendal nerve decompression. Eur J Obstet Gynaecol Reprod Biol 1998;80:215–220.
  36. Tympanidis P, Terenghi G, Dowd P: Increased innervation of the vulval vestibule in patients with vulvodynia. Br J Dermatol 2003;148:1021–1027.
  37. Marinoff SC, Turner ML: Vulvar vestibulitis syndrome: an overview. Am J Obstet Gynaecol 1991;165:1228–1233.
  38. Woodruff JD, Parmerley TH: Infection of the minor vestibular gland. Obstet Gynaecol 1983;62:609–612.
  39. McKay M: Subsets of vulvodynia. J Reprod Med 1988;33:695–698.
  40. Friedrich EG: Vulvar vestibulitis syndrome. J Reprod Med 1987;32:110–114.
  41. Goetsch MF: Vulvar vestibulitis: prevalence and historic features in a general gynecologic practice population. Am J Obstet Gynaecol 1991;164:1606–1611.
  42. Schover LR, Youngs DD, Cannata RN: Psychosexual aspects of the evaluation and management of vulval vestibulitis. Am J Obstet Gynecol 1991;167:630–636.

    External Resources

  43. Bazin S, Bouchard C, Brisson J, Morin C, Meisels A, Fortier M: Vulvar vestibulitis syndrome: an exploratory case-controlled study. Obstet Gynecol 1994;83:47–50.
  44. Peckham BM, Mak DG, Patterson JJ: Focal vulvitis: a characteristic syndrome and a cause of dyspareunia. Am J Obstet Gynecol 1986;154:855–864.
  45. Curnow SH, Barron L, Morrison G, Sergeant P: Vulval algesiometer. Med Biol Eng Comput 1996;34:266–269.
  46. Bergeron S, Binik YM, Khalife S, Pagidas K: Vulvar vestibulitis syndrome: a critical review. Clin J Pain 1997;13:27–42.
  47. Schover LR, Youngs DD, Cannata R: Psychosexual aspects of the evaluation and management of vulvar vestibulitis. Am J Obstet Gynecol 1992;167:630–663.
  48. Furlonge CB, Thin RN, Evans BE, McKee PH: Vulvar vestibulitis syndrome: a clinico-pathological study. Br J Obstet Gynaecol 1991;98:703–706.
  49. Wijma B, Wijma K: A cognitive behavioural treatment model of vaginismus. Scand J Behav Ther 1997;24:147–156.
  50. McKay M: Dysaesthetic vulvodynia. J Reprod Med 1993;38:9–13.
  51. Ridley CM: Vulvodynia: theory and management. Sex Transm Dis 1998;16:775–778.
  52. Mariani L: Vulvar vestibulitis syndrome: an overview of non-surgical treatment. Eur JGynecol Reprod Biol 2002;101:109–112.
  53. Bachmann GA, Rosen R, Arnold LD, Burd I, Rhoads GG, Leiblum SR, Avis N: Chronic vulvar and other gynecologic pain: prevalence and characteristics in a self-reported survey. J Reprod Med 2006;51:3–9.
  54. Backonja M, Beydoun A, Edwards K, Schwartz SL, Fonesca V, Hes M, et al: Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998;280:1831–1836.
  55. Rowbotham M, Harden N, Stacey B, Berstein P, Magnus-Miller L: Gabapentin for the treatment of posttherapeutic neuralgia: a randomized, controlled trial. JAMA 1998;280:1837–1842.
  56. Haefner HK, Collins ME, Davis GD, Edwards L, Foster DC, Hartmann ED, Kaufman RH, Lynch PJ, Margesson LJ, Moyal-Barracco M, Piper CK, Reed BD, Stewart EG, Wilkinson EJ: The vulvodynia guideline (review). J Low Genit Tract Dis 2005;9:40–51.

    External Resources

  57. McCormack WM, Spence MR: Evaluation of the surgical treatment of vulvar vestibulitis. Eur J Obstet Gynecol Reprod Biol 1999;86:135–138.
  58. Kemler MA, Barendse GA, van Kleef M, de Vet HC, Rijks CP, Furnee CA, van den Wildenberg FA: Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. N Engl J Med 2000;343:618–624.
  59. Melzack R, Wall PD: Pain mechanisms: a new theory. Science 1965;150:971–979.
  60. Whiteside JL, Walters MD, Mekhail N: Spinal cord stimulation for intractable vulvar pain: a case report. J Reprod Med 2003;48:821–823.
  61. Faden AI, Jacobs TP, Mougey E, Holaday JW: Endorphins in experimental spinal injury: therapeutic effect of naloxone. Ann Neurol 1981;10:326–332.
  62. Powell J, Wojnarowska F: Acupuncture for vulvodynia. J R Soc Med 1999;92:579–581.
  63. Arezzo JC: Possible mechanisms for the effects of botulinum toxin on pain. Clin J Pain 2002;18:125–132.

    External Resources

  64. Gobel H, Heinze A, Heinze-Kuhn K, Austermann K: Botulinum toxin A in the treatment of headache syndromes and pericranial pain syndromes. Pain 2001;91:195–199.
  65. Guyer BM: Mechanism of botulinum toxin in the relief of chronic pain. Curr Rev Pain 1999;3:427–431.

    External Resources

  66. Lew MF: Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction. Clin J Pain 2002;18:142–146.

    External Resources

  67. Gunter J, Brewer A, Tawfik O: Botulinum toxin a for vulvodynia: a case report. J Pain 2004;5:238–240.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50